{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:10:21Z","timestamp":1753891821775,"version":"3.41.2"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>An obstacle to analysis of the long-term effectiveness of intrathecal (IT) opioids is absence of historical patient baseline data. The electronic Persistent Pain Outcomes Collaboration (ePPOC) is an initiative of the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists. Recently published ePPOC data has provided justifiable surrogate baseline data allowing opportunities for pain outcomes research into select patient treatment groups. Our aim was to compare long-term outcomes of IT opioid therapy with a surrogate baseline utilizing a large ePPOC data set for patients at the time of initial presentation to 36 pain clinics in Australia and New Zealand.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Study participants were 49 consenting patients receiving IT opioids as part of a long-term pain management regime for treating chronic non-cancer pain. Their data were compared with the large ePPOC data set (<jats:italic>n<\/jats:italic>\u2009=\u200913,343). The questionnaires comprised a demographic questionnaire, the Brief Pain Inventory, the Depression, Anxiety and Stress Scale, the Pain Catastrophizing Questionnaire, and the Pain Self-Efficacy Questionnaire.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with the ePOCC group, participants who received IT opioids long-term for the relief of chronic non-cancer pain reported significantly lower (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001) pain severity (4.3 vs. 6.4), and pain interference scores (5.5 vs. 7), significantly lower depression (20.2 vs. 13.7), anxiety (9.6 vs. 14.1), stress (15.5 vs. 21), rumination (6.9 vs. 10), magnification (3.8 vs. 5.9), helplessness (9.7 vs. 14.1), general catastrophizing (20.4 vs. 29.8), and higher self-efficacy (29.5 vs. 20.7).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The observed improvements in all measured pain variables have occurred in the context of comprehensive pain management, and therefore, may be attributable to pain reduction and not directly to IT opioid use or the device itself. Favourable pain management outcomes, in a select patient treatment group utilizing long-term IT opioid therapy, were demonstrated using the large-data ePPOC initiative, highlighting the research opportunities it provides.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpain.2025.1527371","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T07:00:09Z","timestamp":1739516409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of long-term outcomes with intrathecal opioid treatment: a comparison utilizing data derived from pain clinic populations in Australia and New Zealand"],"prefix":"10.3389","volume":"6","author":[{"given":"Elouise Rose","family":"Comber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Strong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orla","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asaduzzaman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Manion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan Joseph","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maree Therese","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2519\/jospt.2018.7605","article-title":"Validity and responsiveness of the pain self-efficacy questionnaire in patients with neck pain disorders","volume":"48","author":"Chiarotto","year":"2018","journal-title":"J Orthop Sports Phys Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/pm\/pny104","article-title":"Long-term outcomes using intrathecal drug delivery systems in complex regional pain syndrome","volume":"20","author":"Herring","year":"2019","journal-title":"Pain Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/j.pain.0000000000001496","article-title":"Normative data for common pain measures in chronic pain clinic populations: closing a gap for clinicians and researchers","volume":"160","author":"Nicholas","year":"2019","journal-title":"Pain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1153001","DOI":"10.3389\/fpain.2023.1153001","article-title":"A decade of outcomes: the evolution of an australasian outcomes collaboration for chronic pain services","volume":"4","author":"Holloway","year":"2023","journal-title":"Front Pain Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/pm\/pnaa076","article-title":"Effects of bupivacaine on opioid patient-controlled intrathecal analgesia in chronic pain patients implanted with drug delivery systems","volume":"22","author":"Hayek","year":"2021","journal-title":"Pain Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/papr.12242","article-title":"The pain self-efficacy questionnaire: cross-cultural adaptation into Italian and assessment of its measurement properties","volume":"15","author":"Chiarotto","year":"2015","journal-title":"Pain Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/ner.12108","article-title":"Physician response to medtronic\u2019s position on the use of off-label medications in the synchromed pump","volume":"16","author":"Rezai","year":"2013","journal-title":"Neuromodulation"},{"key":"B8","first-page":"549","article-title":"Combination intrathecal drug therapy strategies for pain management","volume":"24","author":"Karri","year":"2021","journal-title":"Pain Physician"},{"key":"B9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1046\/j.1440-1681.2000.03290.x","article-title":"Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites","volume":"27","author":"Smith","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/papr.12818","article-title":"Long-term outcome and adverse events of intrathecal opioid therapy for nonmalignant pain syndrome","volume":"20","author":"Sommer","year":"2020","journal-title":"Pain Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/0163278711424282","article-title":"Psychometric evaluation and normative data for the depression, anxiety, and stress scales-21 (DASS-21) in a nonclinical sample of U.S. Adults","volume":"35","author":"Sinclair","year":"2012","journal-title":"Eval Health Prof"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1526-4637.2010.00876.x","article-title":"Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up","volume":"11","author":"Atli","year":"2010","journal-title":"Pain Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1526-4637.2012.01451.x","article-title":"Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain","volume":"13","author":"Hamza","year":"2012","journal-title":"Pain Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"900566","DOI":"10.3389\/fpain.2022.900566","article-title":"Intrathecal drug delivery: advances and applications in the management of chronic pain patient","volume":"3","author":"De Andres","year":"2022","journal-title":"Front Pain Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"721357","DOI":"10.3389\/fpain.2021.721357","article-title":"Opioids and chronic pain: an analytic review of the clinical evidence","volume":"2","author":"Nadeau","year":"2021","journal-title":"Front Pain Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.fitote.2016.02.001","article-title":"Research progress on berberine with a special focus on its oral bioavailability","volume":"109","author":"Liu","year":"2016","journal-title":"Fitoterapia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11013-020-09682-6","article-title":"A cross-cultural perspective on intrathecal opioid therapy between German and Iranian patients","volume":"45","author":"Kleinmann","year":"2021","journal-title":"Cult Med Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/ane.12131","article-title":"Brief pain inventory score identifying and discriminating neuropathic and nociceptive pain","volume":"128","author":"Erdemoglu","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"B19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00002508-200409000-00005","article-title":"Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain","volume":"20","author":"Keller","year":"2004","journal-title":"Clin J Pain"},{"article-title":"The pain catastrophising scale user manual","year":"2009","author":"Sullivan","key":"B20"},{"year":"2017","key":"B21","article-title":"Two Sample T-Test Calculator (Pooled-Variance)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/pm\/pnw201","article-title":"Establishment of the australasian electronic persistent pain outcomes collaboration","volume":"18","author":"Tardif","year":"2017","journal-title":"Pain Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/pm\/pnac110","article-title":"Myth and truth in opioid consumption with intrathecal morphine pump implantation in chronic pain: a retrospective cohort study with claims database in South Korea","volume":"24","author":"Yoo","year":"2022","journal-title":"Pain Med"},{"volume-title":"ePPOC Clinical Reference Manual","year":"2021","key":"B24"},{"key":"B25","first-page":"129","article-title":"Pain assessment: global use of the brief pain inventory. Annals, academy of medicine","volume":"23","author":"Cleeland","year":"1994","journal-title":"Singapore"},{"article-title":"Manual for the depression anxiety stress scales: Psychology Foundation of Australia","year":"1996","author":"Lovibond","key":"B26"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1177\/1073191119887449","article-title":"Examining the dimensionality, reliability, and invariance of the depression, anxiety, and stress scale\u201321 (DASS-21) across eight countries","volume":"28","author":"Zanon","year":"2021","journal-title":"Assessment"},{"key":"B28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1348\/014466503321903544","article-title":"The depression anxiety stress scales (DASS): normative data and latent structure in a large non-clinical sample","volume":"42","author":"Crawford","year":"2003","journal-title":"Br J Clin Psychol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.3390\/ijerph8083287","article-title":"Perceived stress scale: reliability and validity study in Greece","volume":"8","author":"Andreou","year":"2011","journal-title":"Int J Environ Res Public Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2474-13-111","article-title":"Cross-cultural adaptation and validation of the Norwegian pain catastrophizing scale in patients with low back pain","volume":"13","author":"Fernandes","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejpain.2005.12.008","article-title":"The pain self-efficacy questionnaire: taking pain into account","volume":"11","author":"Nicholas","year":"2007","journal-title":"Eur J Pain"},{"year":"2022","key":"B32","article-title":"Chi-Square Calculator"},{"key":"B33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1215\/00703370-8977691","article-title":"Pain trends among American adults, 2002\u20132018: patterns, disparities, and correlates","volume":"58","author":"Zajacova","year":"2021","journal-title":"Demography"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/ner.13167","article-title":"Patient satisfaction following intrathecal targeted drug delivery for benign chronic pain: results of a single-center survey study","volume":"23","author":"Schultz","year":"2020","journal-title":"Neuromodulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/ANA.0b013e31822ff779","article-title":"Long-term intrathecal drug administration for chronic nonmalignant pain","volume":"24","author":"Duarte","year":"2012","journal-title":"J Neurosurg Anesthesiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/ner.12617","article-title":"Intrathecal opioid therapy for non-malignant chronic pain: a long-term perspective","volume":"20","author":"Kleinmann","year":"2017","journal-title":"Neuromodulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1213\/ANE.0000000000005662","article-title":"Perioperative opioid consumption and clinical outcomes in surgical patients with a Pre-existing opioid-based intrathecal drug delivery system","volume":"134","author":"D\u2019Souza","year":"2022","journal-title":"Anesth Analg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"575168","DOI":"10.5402\/2012\/575168","article-title":"Complications of intrathecal baclofen pump: prevention and cure","volume":"2012","author":"Awaad","year":"2012","journal-title":"Int Sch Res Notices"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2025.1527371\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T07:00:12Z","timestamp":1739516412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2025.1527371\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":38,"alternative-id":["10.3389\/fpain.2025.1527371"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2025.1527371","relation":{},"ISSN":["2673-561X"],"issn-type":[{"type":"electronic","value":"2673-561X"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"article-number":"1527371"}}